Enhanced formulations for neutralization of chemical, biological and industrial toxants

Details for Australian Patent Application No. 2002341750 (hide)

Owner Sandia Corporation

Inventors Tucker, Mark D

Agent Peter Maxwell & Associates

Pub. Number AU-B-2002341750

PCT Number PCT/US02/29886

PCT Pub. Number WO2003/028429

Priority 60/334,271 30.11.01 US; 60/387,104 07.06.02 US; 60/326,508 01.10.01 US

Filing date 20 September 2002

Wipo publication date 14 April 2003

Acceptance publication date 11 October 2007

International Classifications

A62D 3/38 (2007.01) Processes for making harmful chemical substances harmless, or less harmful, by effecting a chemical change in the substances

B01F 17/18 (2006.01) Use of substances as emulsifying, wetting, dispersing, or foam-producing agents - Quaternary ammonium compounds

B01F 17/38 (2006.01) Use of substances as emulsifying, wetting, dispersing, or foam-producing agents - Alcohols, e.g. oxidation products of paraffins

C09K 3/00 (2006.01) Materials not provided for elsewhere

A62D 101/02 (2007.01)

Event Publications

27 February 2003 Complete Application Filed

  Priority application(s): 60/334,271 30.11.01 US; 60/387,104 07.06.02 US; 60/326,508 01.10.01 US

26 June 2003 Application Open to Public Inspection

  Published as AU-B-2002341750

11 October 2007 Application Accepted

  Published as AU-B-2002341750

7 February 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002341751-ONLINE TRADING FOR THE PLACEMENT OF ADVERTISING IN MEDIA

2002341749-METHODS AND COMPOSITIONS FOR INHIBITING THE PROLIFERATION OF PROSTATE CANCER CELLS